BibTex RIS Kaynak Göster

Is the presence of diffuse gastric hypermetabolism enough to exclude a gastric tumour?

Yıl 2013, , 176 - 177, 30.09.2015
https://doi.org/10.5472/MMJ.2013.02828.1

Öz

Is the presence of diffuse gastric hypermetabolism enough to exclude a gastric tumour?

Kaynakça

  • Shreve P, Anzai Y, Wahl R. Pitfalls in oncologic diagnosis with FDG PET imaging: physiologic and benign variants. Radiographics 1999;19:61–77.
  • Cook GJR, Fogelman I, Maisey M. Normal physiological and benign pathological variants of 18-fluoro-2-deoxyglucose positron emission tomography scanning: potential for error in interpretation. Semin Nucl Med 1996;24:308-14. doi: 10.1016/S0001-2998(96)80006-7
  • Bischof-Delaloye A, Wahl RL. How high a level of FDG abdominal activity is considered normal? J Nucl Med 1995; 36(suppl):106P. Horton KM, Fishman EK. Helical CT of the stomach: evaluation with water as an oral contrast agent. AJR 1998;171:1373-6. doi: 10.2214/ ajr.15.9798881
  • Mijin Y, Hyun S C, Eunhye Y, et al. The role of gastric distention in differentiating recurrent tumor from physiologic uptake in the remnant stomach on 18F-FDG PET. J Nucl Med 2005;46:953-7.

Is the presence of diffuse gastric hypermetabolism enough to exclude a gastric tumour?

Yıl 2013, , 176 - 177, 30.09.2015
https://doi.org/10.5472/MMJ.2013.02828.1

Öz

-

Kaynakça

  • Shreve P, Anzai Y, Wahl R. Pitfalls in oncologic diagnosis with FDG PET imaging: physiologic and benign variants. Radiographics 1999;19:61–77.
  • Cook GJR, Fogelman I, Maisey M. Normal physiological and benign pathological variants of 18-fluoro-2-deoxyglucose positron emission tomography scanning: potential for error in interpretation. Semin Nucl Med 1996;24:308-14. doi: 10.1016/S0001-2998(96)80006-7
  • Bischof-Delaloye A, Wahl RL. How high a level of FDG abdominal activity is considered normal? J Nucl Med 1995; 36(suppl):106P. Horton KM, Fishman EK. Helical CT of the stomach: evaluation with water as an oral contrast agent. AJR 1998;171:1373-6. doi: 10.2214/ ajr.15.9798881
  • Mijin Y, Hyun S C, Eunhye Y, et al. The role of gastric distention in differentiating recurrent tumor from physiologic uptake in the remnant stomach on 18F-FDG PET. J Nucl Med 2005;46:953-7.
Toplam 4 adet kaynakça vardır.

Ayrıntılar

Birincil Dil İngilizce
Bölüm Makaleler
Yazarlar

Salih Özgüven Bu kişi benim

Yayımlanma Tarihi 30 Eylül 2015
Yayımlandığı Sayı Yıl 2013

Kaynak Göster

APA Özgüven, S. (2015). Is the presence of diffuse gastric hypermetabolism enough to exclude a gastric tumour?. Marmara Medical Journal, 26(3), 176-177. https://doi.org/10.5472/MMJ.2013.02828.1
AMA Özgüven S. Is the presence of diffuse gastric hypermetabolism enough to exclude a gastric tumour?. Marmara Med J. Eylül 2015;26(3):176-177. doi:10.5472/MMJ.2013.02828.1
Chicago Özgüven, Salih. “Is the Presence of Diffuse Gastric Hypermetabolism Enough to Exclude a Gastric Tumour?”. Marmara Medical Journal 26, sy. 3 (Eylül 2015): 176-77. https://doi.org/10.5472/MMJ.2013.02828.1.
EndNote Özgüven S (01 Eylül 2015) Is the presence of diffuse gastric hypermetabolism enough to exclude a gastric tumour?. Marmara Medical Journal 26 3 176–177.
IEEE S. Özgüven, “Is the presence of diffuse gastric hypermetabolism enough to exclude a gastric tumour?”, Marmara Med J, c. 26, sy. 3, ss. 176–177, 2015, doi: 10.5472/MMJ.2013.02828.1.
ISNAD Özgüven, Salih. “Is the Presence of Diffuse Gastric Hypermetabolism Enough to Exclude a Gastric Tumour?”. Marmara Medical Journal 26/3 (Eylül 2015), 176-177. https://doi.org/10.5472/MMJ.2013.02828.1.
JAMA Özgüven S. Is the presence of diffuse gastric hypermetabolism enough to exclude a gastric tumour?. Marmara Med J. 2015;26:176–177.
MLA Özgüven, Salih. “Is the Presence of Diffuse Gastric Hypermetabolism Enough to Exclude a Gastric Tumour?”. Marmara Medical Journal, c. 26, sy. 3, 2015, ss. 176-7, doi:10.5472/MMJ.2013.02828.1.
Vancouver Özgüven S. Is the presence of diffuse gastric hypermetabolism enough to exclude a gastric tumour?. Marmara Med J. 2015;26(3):176-7.